SCHEMBL4193523

SCHEMBL4193523

CC(CC1CCCCC1)NC(=O)NCc1ccccc1NS(=O)(=O)c1ccc(Br)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
POLB P06746 2/20 0.51
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.43
ALDH1A1 P00352 5/20 0.42
HTT P42858 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.41
HSP90AA1 P07900 1/20 0.40
HPGD P15428 1/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38
NFKBIA P25963 1/20 0.37
RELA Q04206 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4192908 0.86 MEN1 (0.49) MEN1KMT2APOLBTP53MAPT
SCHEMBL4195126 0.86 NPC1 (0.44) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL4189960 0.84 KDM4E (0.49) MEN1KMT2APOLBTP53MAPT
Methane SCHEMBL4708292 0.83 KDM4E (0.48) MEN1KMT2APOLBTP53MAPT
SCHEMBL4708027 0.83 MEN1 (0.49) MEN1KMT2APOLBTP53MAPT
SCHEMBL4193542 0.83 ALDH1A1 (0.42) KMT2AALDH1A1HPGDKDM4EPKM
SCHEMBL4193066 0.82 KDM4E (0.59) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL4195578 0.81 LMNA (0.52) MEN1KMT2APOLBTHRBALDH1A1
SCHEMBL12050351 0.77 PKM (0.44) MEN1KMT2APOLBTP53MAPT
SCHEMBL4192333 0.75 KDM4E (0.42) MEN1KMT2APOLBMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
CN-101203504-A Antimicrobial agents RANBAXY LAB LTD (IN) 2008-06-18 CN claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
CN-101203504-B Antimicrobial agents RANBAXY LAB LTD 2012-11-14 CN disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
CN-101203504-A Antimicrobial agents RANBAXY LAB LTD (IN) 2008-06-18 CN disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 MEN1 3776/4885KMT2A 2047/4885POLB 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.